About usHistoryCulture
EHS SystemQuality System
APICDMO
Work PhilosophyRecruitment News
To be the Reliable Supplier in the Global Pharmaceutical Supply Chain
Home > Business >
API CDMO
Cas No.：169869-90-3
Status：R&D Stage
Exatecan mesylate (DX8951f) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL). Exatecan mesylate can be used in cancer research.
E-mail Product Inquiry
Title：
Cas No.：
Name：
Telephone：
E-mail：
Message：
Submit
